Strategy to Avoid Excessive Oxygen in Major Burn Patients

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

November 15, 2022

Study Completion Date

December 31, 2025

Conditions
Critical IllnessWounds and InjuryDisease AttributesPathologic Processes
Interventions
OTHER

Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg)

Post-implementation of targeted normoxemia through oxygen titration for individual patients. Intervention for treatment of hypoxemia will follow usual local practice. Interventions for treatment of hyperoxemia (SpO2 \>96% or PaO2 \> 100 mmHg) will involve down titration of FiO2 (or supplemental oxygen for non-mechanically ventilated patients) within a time frame based on local site preferences-typically in increments of no greater than 0.10 until goal oxygenation in the normoxemia range is achieved (including room air \[no supplemental oxygen\] for non-mechanically ventilated patients).

Trial Locations (6)

15224

University of Pittsburgh Medical Center, Pittsburgh

35294

University of Alabama-Birmingham Medical Center, Birmingham

37232

Vanderbilt University Medical Center, Nashville

45219

University of Cincinnati Medical Center, Cincinnati

78234

Army Institute of Surgical Research, San Antonio

80045

University of Colorado, Aurora

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

University of Colorado, Denver

OTHER